BiondVax to Present at H.C. Wainwright 24th Annual Global Investment Conference
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Source: prnewswire.com